11β-HSD1 |
11β-hydroxysteroid dehydrogenase type 1 |
A2780 |
Human ovarian cancer cells |
A549 |
Human lung adenocarcinoma cells |
C6 |
Cellosaurus cell line |
Colo320 |
Human colon adenocarcinoma cells |
DOX |
Doxorubicin |
DPPH |
1,1-diphenyl-2-pycrylhydrazyl |
DU-145 |
Human prostate cancer cells |
EBV-EA |
Epstein-Barr virus cells |
GI50 |
Growth inhibition—concentration at which cell is inhibited by 50% |
HCT 116 |
Human colorectal adenocarcinoma cells |
HeLa |
Human normal cells |
HepG2 |
Human liver carcinoma cells |
HL60 |
Promyelocytic leukemia cells |
HT-3 |
Human cervix cells |
IC50
|
Inhibitory concentration |
K562 |
Human immortalized myelogenous leukemia cells |
MCF-7 |
Human breast cancer cell lines |
MDR1 |
Multidrug resistance gene 1 |
MRC-5 |
Human embryonic fibroblast cell lines |
MTT |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
P-gp |
Permeability glycoprotein |
SGC-7901 |
Human gastric cancer cell line |
SMMC-7721 |
Human hepatoma cell line |
SRB |
Sulforhodamine B assay |
TNFR1 |
Tumor necrosis factor receptor 1 |
U937 |
Human myeloid leukemia |